Researchers have made a new discovery in the fight against malaria. The study, recently published in Science, identified a new class of antibodies targeting a previously unexplored malaria parasite region.
Dr Stefan H. Bossmann and Dr Christopher T. Culbertson, Professors of Chemistry at Kansas State University, explain why microfluidic devices are in their view, the future.
Barbara Harpham, Chair of the Medical Technology Group, wants to see healthcare spending, particularly on medical technology, linked to tangible outcomes for patients, the economy and society.
Chief Executive of Brain Tumour Research, Sue Farrington Smith MBE, outlines the priorities for research into brain tumours and why it is imperative we overcome this uniquely devastating cancer.
A novel sensor designed by MIT researchers could dramatically accelerate the process of diagnosing sepsis, a leading cause of death in U.S. hospitals that kills nearly 250,000 patients annually.
Authorities have failed to ensure for almost 30 years that Basra residents have sufficient clean water in Iraq, resulting in on-going health concerns, Human Rights Watch said in a report.
The University of Cambridge found that virtual reality (VR) can identify early Alzheimer’s disease better than ‘gold standard’ cognitive tests currently in use.
Oxford University researchers have discovered a brain process common to sleep and ageing in research that could pave the way for new treatments for insomnia.
Scientists at the University of Cambridge have developed a new test that can reliably predict the future course of inflammatory bowel disease (IBD) in individuals, transforming treatments for patients.
King's College London researchers found that cannabidiol (CBD) could hold promise as a treatment for psychosis, according to reasonable benefits seen in a clinical trial.
Around four million people in the UK carry genetic variants that protect them from obesity, type 2 diabetes and heart disease, suggests new research from the University of Cambridge.
